Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) : Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) announcement on application for 2022 comprehensive credit line and related guarantee matters

Securities code: Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) securities abbreviation: Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Announcement No.: 2022013 bond Code: 113585 bond abbreviation: Shouxian convertible bond

Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896)

Announcement on applying for comprehensive credit line and related guarantee matters in 2022

The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.

Important content tips:

Name of the guaranteed:

1. Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) (hereinafter referred to as “the company”)

2. Jinhua Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Pharmaceutical Co., Ltd. (hereinafter referred to as ” Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) pharmaceutical”)

3. Wuyi Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) traditional Chinese medicine decoction pieces Co., Ltd. (hereinafter referred to as ” Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) decoction pieces”)

4. Jinhua Kangshou Pharmaceutical Co., Ltd. (hereinafter referred to as “Kangshou pharmaceutical”)

The guarantee amount and the guarantee balance actually provided for it

The company plans to provide the above wholly-owned subsidiaries with a guarantee line of RMB 800 million within the comprehensive credit line. As of the date of this announcement, the actual guarantee balance provided for the holding subsidiaries is RMB 10000.

Whether there is counter guarantee in this guarantee: None

Cumulative overdue amount of external guarantee: None

1、 Overview of application for comprehensive credit and related guarantees

In order to ensure the smooth realization of the company’s business target in 2022, and to ensure the smooth realization of the company’s business target in 2022, according to the arrangement of the company’s capital budget, the company and its wholly-owned subsidiary, the company’s and its wholly-owned subsidiary, the company’s and the company’s capital budget, the company’s and the wholly-owned subsidiary’s Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) 03896 \3536 Jinhua Branch, Industrial Bank Co.Ltd(601166) Yiwu Branch Bank Of Ningbo Co.Ltd(002142) financial institutions including Jinhua Wuyi small and micro enterprise franchise sub branch and China Citic Bank Corporation Limited(601998) Wuyi sub branch apply for comprehensive credit and credit lines with a total amount of no more than 800 million yuan, and authorize the company and its wholly-owned subsidiaries to guarantee each other with their own credit or assets for a period of less than two years, and authorize the general manager or chief financial officer of the company to handle the above matters on behalf of the company, The authorization shall be valid for one year from the date of deliberation and approval by the general meeting of shareholders.

The application for comprehensive credit line and related guarantee matters need to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.

2、 Basic information of the guaranteed

(Ⅰ) Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896)

Company name Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896)

Unified social credit code 91330700147493495c

Registered address: No. 10, Shangcheng Road, Hushan street, Wuyi County, Zhejiang Province

The registered capital is 143444784 million yuan

Legal representative: Li Mingyan

Date of establishment: March, 1997

Pharmaceutical trading and TCM services (the above business scope is only limited to branches); Sales of stereotyped packaged food; Wholesale of edible fungi; Fried vegetables (including dried tea products) and dried tea products; Research on traditional Chinese medicine (except those prohibited or restricted by national laws and regulations); Planting, purchasing and selling of native Chinese medicinal materials (except narcotic drugs, original medicinal plants, licorice and ephedra), vegetables, fruits and edible fungi; Sub packaging of primary edible agricultural and sideline products; Training and consultation on edible fungus planting technology; Tourism resource management; Import and export of goods and technology, planting and sales of cereals and potatoes; Testing services for cosmetics, food and drugs; Non medical health knowledge consultation service; Sales of cosmetics and washing products; Pastry processing; Aquaculture, processing and sales of aquatic products; Preparation for the establishment of for-profit medical institutions (only branches can operate with licenses).

As of December 31, 2021, the main financial data of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) total assets are 1591059700 yuan, and the net assets are 1430252000 yuan; In 2021, the operating revenue was 342330800 yuan and the net profit was 101844800 yuan.

(II) Jinhua Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Pharmaceutical Co., Ltd

Company name: Jinhua Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Pharmaceutical Co., Ltd

Unified social credit code 91330723753960591d

Registered address: No. 10, Shangcheng Road, Wuyi County, Jinhua City, Zhejiang Province

The registered capital is 129.99 million yuan

Legal representative: Li Zhenyu

Date of establishment: August 27, 2003

Composition of shareholders Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) holds 100% equity

Food production (see the license for the specific business scope); Wholesale and retail of prepackaged food and bulk food and dairy products (see the license for specific business scope). Research and development of new varieties, new technologies and business scope of traditional Chinese medicine; Research and development of intermediates of traditional Chinese medicine; Cultivation, planting, promotion and sales of traditional Chinese medicine; Retail of daily necessities, hardware and electrical appliances and stationery; Testing services for cosmetics, food and drugs (operated with effective qualifications); Production and sales of cosmetics and washing products (operated with a valid license); Non medical health knowledge consultation service.

As of December 31, 2021, Jinhua Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Pharmaceutical Co., Ltd. has total assets of 703768800 yuan and net assets of 261742600 yuan according to main financial data; In 2021, the operating revenue was 501887 million yuan and the net profit was 158806 million yuan.

(III) Wuyi Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) traditional Chinese medicine decoction pieces Co., Ltd

Company name: Wuyi Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) traditional Chinese medicine decoction pieces Co., Ltd

Unified social credit code 913307236807125615

Registered address: Huanglong Industrial Zone, Hushan street, Wuyi County, Jinhua City, Zhejiang Province

The registered capital is 129.99 million yuan

Legal representative: Li Mingyan

Date of establishment: September 25, 2008

Composition of shareholders Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) holds 100% equity

General items: cosmetics wholesale; Cosmetics retail; Health consulting services (excluding diagnosis and treatment services) (except for the items that must be approved according to law, carry out business activities independently according to law with the business license). Permitted business scope: drug production; Wholesale of drugs; Drug retail; Food business; Inspection and testing services (for items that must be approved according to law, business activities can be carried out only after being approved by relevant departments, and the specific business items shall be subject to the approval results).

As of December 31, 2021, Wuyi Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) traditional Chinese medicine decoction pieces Co., Ltd. had total assets of 9247933 million yuan, main financial data and net assets of 6991654 million yuan; The annual operating profit was RMB 11.259 million and the annual net profit was RMB 11.215 million..

(IV) Jinhua Kangshou Pharmaceutical Co., Ltd

Company name: Jinhua Kangshou Pharmaceutical Co., Ltd

Unified social credit code 91330723ma28d1k92x

Registered address: No. 12-1, Huanglong Third Road, Hushan street, Wuyi County, Jinhua City, Zhejiang Province

Registered capital: 50 million yuan

Legal representative: Li Mingyan

Date of establishment: October 21, 2015

Composition of shareholders Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) holds 100% equity

Business scope: drug production (see the license for specific business scope)

As of December 31, 2021, the total assets of Jinhua Kangshou Pharmaceutical Co., Ltd. were 240433 million yuan, and the net assets of main financial data were 201287 million yuan; In 2021, the operating income was 793600 yuan and the net profit was -4257900 yuan.

3、 Main contents of the guarantee agreement

The above guarantee is the estimated amount of guarantee of the company and its subsidiaries in 2022. Matters related to the guarantee need to be reviewed and approved by banks and other financial institutions. At present, no guarantee contract or agreement has been signed with banks and other financial institutions. The actual guarantee amount, guarantee period and other terms will be subject to the guarantee contract or agreement actually signed and occurred.

4、 Opinions of the board of directors

On March 31, 2022, the 32nd meeting of the third board of directors of the company deliberated and approved the proposal on the company’s application for comprehensive credit line and related guarantee matters in 2022, agreed that the company and its wholly-owned subsidiaries should apply to financial institutions for comprehensive credit and credit line with a total amount of no more than RMB 800 million, and authorized the company and its wholly-owned subsidiaries to guarantee each other with their own credit or assets with respect to the above-mentioned credit and credit line, The term is within two years, and the general manager or chief financial officer of the company is authorized to handle the above matters on behalf of the company. The authorization is valid within one year from the date of deliberation and approval by the general meeting of shareholders.

5、 Accumulated external guarantees and overdue guarantees

1. As of the date of this announcement, except for this guarantee, the company and its subsidiaries have no external guarantee. The total amount of guarantee actually provided by the company to its holding subsidiaries is RMB 10000, accounting for 0.00% of the company’s latest audited net assets.

2. The company has no violation or overdue guarantee.

It is hereby announced.

Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) board of directors April 1, 2022

- Advertisment -